Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

September 30, 2019 โ€“ Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy ...

Home September 30, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

September 26, 2019 โ€” New data from the Phase IV independent TWILIGHT trial showed Brilinta (ticagrelor) monotherapy redu ...

Home September 26, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

September 20, 2019 โ€” Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those ...

Home September 20, 2019
Home
News | Heart Failure

September 18, 2019 โ€” AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Home September 18, 2019
Home
News | Heart Failure

September 11, 2019 โ€” The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...

Home September 11, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

September 10,2019 โ€” The combination of ticagrelor and aspirin reduces ischemic events compared with aspirin alone in ...

Home September 10, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

September 9, 2019 โ€” Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary ...

Home September 09, 2019
Home
News | Heart Failure

September 9, 2019 โ€” AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...

Home September 09, 2019
Home
News | Heart Failure

September 9, 2019 โ€” The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...

Home September 09, 2019
Home
News | Heart Failure

September 4, 2019 โ€“ Novartis announced results from two new clinical trials evaluating improvement in heart structure ...

Home September 04, 2019
Home
News | Cath Lab

August 27, 2019 โ€” Imagine there were a drug that you could take soon after a heart attack that could reduce damage by ...

Home August 27, 2019
Home
News | Peripheral Artery Disease (PAD)

August 23, 2019 โ€“ Patients with peripheral artery disease (PAD) were significantly less likely to face amputation after ...

Home August 23, 2019
Home
Coronary CT angiography images of a coronary artery depicting the perivascular fat attenuation index (FAI) before and after biologic therapy at one-year follow-up. Patients had excellent response to biologic therapy, showing clear reductions in the inflammation in plaques that cause heart attacks and stokes. Image from the Oxford Academic Cardiovascular CT Core Lab and Lab of Inflammation and Cardiometabolic Diseases at NHLBI.
Feature | Pharmaceuticals

July 31, 2019 โ€” Researchers found anti-inflammatory drug therapies used to treat moderate to severe psoriasis can ...

Home July 31, 2019
Home
News | Cardio-oncology

July 29, 2019 โ€” Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest ...

Home July 29, 2019
Home
Subscribe Now